학술논문
Altiratinib inhibits tumor growth, invasion, angiogenesis, and microenvironment-mediated drug resistance via balanced inhibition of MET, TIE2, and VEGFR2
Document Type
Article
Author
Smith, B.D.; Kaufman, M.D.; Leary, C.B.; Turner, B.A.; Wise, S.C.; Ahn, Y.M.; Booth, R.J.; Caldwell, T.M.; Ensinger, C.L.; Hood, M.M.; Lu, W.-P.; Patt, T.W.; Patt, W.C.; Rutkoski, T.J.; Samarakoon, T.; Telikepalli, H.; Vogeti, L.; Vogeti, S.; Yates, K.M.; Clare, M.; Flynn, D.L.; Chun, L.; Stewart, L.J.
Source
In: Molecular Cancer Therapeutics . (Molecular Cancer Therapeutics, 1 September 2015, 14(9):2023-2034)
Subject
Language
English
ISSN
15388514
15357163
15357163